News stories about Mindray Medical International (NYSE:MR) have trended somewhat positive this week, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Mindray Medical International earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned media stories about the medical instruments supplier an impact score of 48.4762448733126 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Shares of Mindray Medical International (MR) opened at $27.94 on Friday. The company has a market capitalization of $3,310.00 and a P/E ratio of 18.75. Mindray Medical International has a 12-month low of $27.85 and a 12-month high of $27.95.
About Mindray Medical International
Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature.
Receive News & Ratings for Mindray Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International and related companies with MarketBeat.com's FREE daily email newsletter.